SCHEMBL3966040

SCHEMBL3966040

CCCCNc1ccccc1CC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.60
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TLR8 Q9NR97 1/20 0.46
UTS2R Q9UKP6 1/20 0.45
ALDH1A1 P00352 3/20 0.45
APAF1 O14727 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10407866 0.94 POLB (0.54) POLBCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10408718 0.92 POLB (0.53) POLBALDH1A1ELANEL3MBTL1HTT
SCHEMBL10407954 0.92 POLB (0.53) POLBALDH1A1ELANEL3MBTL1HTT
SCHEMBL3248990 0.92 POLB (0.53) POLBALDH1A1ELANEL3MBTL1HTT
SCHEMBL2917100 0.88 POLB (0.50) POLBALDH1A1HDAC3HDAC4HDAC1
SCHEMBL30806170 0.87 MAPT (0.54) POLBALDH1A1HDAC3HDAC4HDAC1
SCHEMBL10408180 0.86 POLB (0.46) POLBCYP1A2CYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL2343034 0.85 MAPT (0.52) POLBALDH1A1HDAC3HDAC4HDAC1
SCHEMBL309485 0.85 TLR8 (0.53) POLBCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5255929 0.85 POLB (0.45) POLBALDH1A1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839144-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-12-05 US disclosed
US-20230183453-A1 SILANE FUNCTIONAL AMINE COMPOSITIONS AND THEIR USE IN RUBBER MOMENTIVE PERFORMANCE MATERIALS INC. 2023-06-15 US disclosed
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-09-17 US disclosed
US-9941479-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-10 US disclosed
US-20150349279-A1 Tetradentate Cyclometalated Platinum Complexes Containing 9,10-Dihydroacridine And Its Analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-12-03 US disclosed
CN-101146777-B Carboxylic anilide microbicide SYNGENTA PARTICIPATIONS AG 2010-12-08 CN disclosed
WO-2009038006-A1 RANDOM COPOLYMER AND PRODUCTION PROCESS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-03-26 WO disclosed
US-4352696-A Process and composition THE UPJOHN COMPANY (US) 1982-10-05 US disclosed
US-4257995-A STORAGE STABILITY THE UPJOHN COMPANY (US) 1981-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150349279-A1 Tetradentate Cyclometalated Platinum Complexes Containing 9,10-Dihydroacridine And Its Analogues DPYD, DCTD, TYMP POLB 179/4885CYP1A2 4810/4885CYP3A4 4503/4885
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS DDT, MPST, STOM POLB 4665/4885CYP1A2 1497/4885CYP3A4 1836/4885
US-11839144-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues DPYD, DCTD, TYMP POLB 179/4885CYP1A2 4810/4885CYP3A4 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.